News
NPHC
0.0001
NaN%
--
Weekly Report: what happened at NPHC last week (0609-0613)?
Weekly Report · 4d ago
Weekly Report: what happened at NPHC last week (0602-0606)?
Weekly Report · 06/09 12:09
Weekly Report: what happened at NPHC last week (0526-0530)?
Weekly Report · 06/02 12:21
Weekly Report: what happened at NPHC last week (0519-0523)?
Weekly Report · 05/26 12:20
Weekly Report: what happened at NPHC last week (0512-0516)?
Weekly Report · 05/19 12:07
Weekly Report: what happened at NPHC last week (0505-0509)?
Weekly Report · 05/12 12:08
Weekly Report: what happened at NPHC last week (0428-0502)?
Weekly Report · 05/05 12:11
Weekly Report: what happened at NPHC last week (0421-0425)?
Weekly Report · 04/28 12:24
Weekly Report: what happened at NPHC last week (0414-0418)?
Weekly Report · 04/21 12:23
Weekly Report: what happened at NPHC last week (0407-0411)?
Weekly Report · 04/14 12:08
Weekly Report: what happened at NPHC last week (0331-0404)?
Weekly Report · 04/07 12:07
Weekly Report: what happened at NPHC last week (0324-0328)?
Weekly Report · 03/31 12:24
Weekly Report: what happened at NPHC last week (0317-0321)?
Weekly Report · 03/24 12:07
Weekly Report: what happened at NPHC last week (0310-0314)?
Weekly Report · 03/17 12:22
Weekly Report: what happened at NPHC last week (0303-0307)?
Weekly Report · 03/10 12:24
Weekly Report: what happened at NPHC last week (0224-0228)?
Weekly Report · 03/03 12:23
Weekly Report: what happened at NPHC last week (0217-0221)?
Weekly Report · 02/24 12:23
Weekly Report: what happened at NPHC last week (0210-0214)?
Weekly Report · 02/17 12:19
Weekly Report: what happened at NPHC last week (0203-0207)?
Weekly Report · 02/10 12:10
Weekly Report: what happened at NPHC last week (0127-0131)?
Weekly Report · 02/03 12:17
More
Webull provides a variety of real-time NPHC stock news. You can receive the latest news about Nutra Pharma Corp through multiple platforms. This information may help you make smarter investment decisions.
About NPHC
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. The Company's drug candidates include RPI-MN and RPI-78M. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin and Pet Pain-Away. Its pain relief categories include arthritis pain, chronic back pain, headaches and migraines, and knee and joint pain. Its over the counter (OTC) homeopathic products include Nyloxin Topical Gel, Extra Strength Nyloxin Topical Gel, Nyloxin Oral Spray, Extra Strength Nyloxin Oral Spray, Nyloxin Topical Gel Roll On, Nyloxin Professional Size Pump Topical Gel and Pet Pain Away. The Company's holds approximately 21 patents in their portfolio.